Clinical trials: Developmental Dislocation of the Hip
Developmental Dysplasia of the Hip
Treatment for Mild Hip Dysplasia in Newborns
Developmental dysplasia of the hip is the most common musculoskeletal disorder in infancy, with a reported prevalence of 2% of all newborns.
- Trial name
- NCT00843258
- Testing
- Abduction treatment
- Volunteers
- 140 people
- Sponsor
- University of Bergen
Congenital Hip Dysplasia
Pericapsular Nerve Group (PENG) Block for Congenital Hip Dislocation Surgery
Developmental dysplasia of the hip (DDH) is one of the major disorder of the pediatric population with an incidence of 3 to 5 per 1000 children.
- Trial name
- NCT04212039
- Testing
- Saline Solution, Bupivacaine
- Where
- Turkey (Türkiye)
- Volunteers
- 48 people
- Sponsor
- Ataturk University
Hip Developmental Dysplasia
Effect of Cross-legged Sitting Among Patients With Unilateral Hip Developmental Dysplasia
One of the most common infant developmental diseases is Hip dysplasia which is mostly seen among female' babies and leads to hip instability due to partial or full hip dislocation [1].
- Trial name
- NCT07002840
- Testing
- Cross- legged sitting position, Physical Therapy Rehabilitation Program
- Volunteers
- 16 people
- Sponsor
- Jouf University
Developmental Dysplasia of the Hip
Hip Arthroscopy Versus Conservative Treatment for Borderline Hip Dysplasia
The goal of this clinical trial is to compare the efficacy of hip arthroscopy versus individualized conservative treatment in patients with borderline developmental dysplasia of the hip (BDDH), defined by a lateral center-edge…
- Trial name
- NCT07493746
- Testing
- Hip arthroscopy, Individualized conservative treatment
- Volunteers
- 248 people
- Sponsor
- ChunBao Li
Developmental Dysplasia of the Hip
Mid-term Functional Comparisons of Unilateral and Bilateral Developmental Dysplasia of the Hip
The annual number of live births in Türkiye is 1,112,859 in 2020 and the estimated incidence of developmental dysplasia of the hip (DDH) is between 5 and 15 per 1000 live births.
- Trial name
- NCT05853510
- Where
- Turkey (Türkiye)
- Volunteers
- 35 people
- Sponsor
- Pamukkale University
Osteoarthritis of Hip, Congenital Hip Dysplasia
Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
The study will evaluate the radiographs (x-rays) of 100 patients with a TriFIT total hip at 2 weeks, 3 months, 6 months, 12 months, and yearly following surgery to see if there has been any movement or wear in the hip stem over…
- Conditions
- Osteoarthritis of Hip, Congenital Hip Dysplasia, Avascular Necrosis
- Trial name
- NCT02162186
- Where
- Canada
- Volunteers
- 37 people
- Sponsor
- Corin
Osteoarthritis, Hip, Femur Head Necrosis
Efficiency and Safety of Navigation Aids in Total Hip Arthroplasty With Direct Anterior Approach
This retrospective cohort study aimed to evaluate the effectiveness of an imageless navigation system in total hip arthroplasty (THA) via the direct anterior approach (DAA) on a traction table for reducing functional limb length…
- Conditions
- Osteoarthritis, Hip, Femur Head Necrosis, Developmental Dysplasia of the Hip
- Trial name
- NCT07134036
- Testing
- Navigation system, Conventional total hip arthroplasty
- Where
- Taiwan
- Volunteers
- 72 people
- Sponsor
- China Medical University Hospital
Developmental Dysplasia of the Hip
Ultrasound Quadratus Lumborum Block Vs Fascia Iliaca Block in Pediatrics Undergoing Hip Surgery .
Comparison between ultrasound guided transmuscular QL block and Fascia iliaca block in pediatric patients undergoing DDH surgery regarding the quality of pain control in the perioperative period..
- Trial name
- NCT05282849
- Testing
- ultrasound guided fascia iliaca block, ultrasound guided quadratus lumborum block
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Cairo University
Developmental Dysplasia of Hip
Using Artificial Intelligence to Screen for Hip Dysplasia
The goal of this clinical trial is to learn if an ultrasound scan using artificial intelligence can accurately screen for hip dysplasia.
- Trial name
- NCT06647225
- Testing
- Artificial intelligence augmented ultrasound
- Where
- Australia
- Volunteers
- 240 people, healthy volunteers welcome
- Sponsor
- Murdoch Childrens Research Institute
Primary Osteoarthritis, Post-Traumatic Arthritis
AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study
This is a Post Marketing Clinical Follow Up study (PMCF) on the AVANTAGE RELOAD dual mobility system cup.
- Conditions
- Primary Osteoarthritis, Post-Traumatic Arthritis, Inflammatory Joint Disease, Femoral Neck Fracture
- Trial name
- NCT03357445
- Testing
- Avantage Reload cup
- Where
- 4 sites in France, Slovenia
- Volunteers
- 500 people
- Sponsor
- Zimmer Biomet
Developmental Dysplasia of the Hip
Prospective Cohort Study of Arthroscopic Treatment of Hip Dysplasia
On the basis of the database established in the previous stage, a cohort analysis was conducted on patients with BDDH complicated by hip arthroscopy for minimally invasive treatment of glenoid and lip injury, according to which…
- Trial name
- NCT06512506
- Testing
- non-intervention
- Where
- China
- Volunteers
- 47 people
- Sponsor
- Peking University Third Hospital
Developmental Dysplasia of the Hip
Assessing a Limited Ultrasound Protocol in DDH
Developmental Dysplasia of the Hip (DDH) is a common diagnosis in children that if untreated may lead to degeneration and arthritis of the hip joint at a young age.
- Trial name
- NCT03608475
- Testing
- Limited Ultrasound Imaging, Standard Ultrasound Imaging
- Where
- Canada
- Volunteers
- 100 people
- Sponsor
- The Hospital for Sick Children
Congenital Hip Dysplasia
Early Abduction Splintage on Stable Hips in Infants With Developmental Dysplasia of the Hip
The aim of this study is to prove the improvement of pubo-femoral distance by early abduction splintage in one-month-old infants with developmental dysplasia of the hip (with a clinical stable hip but an abnormal hip…
- Trial name
- BBH (NCT02885831)
- Testing
- Abduction splintage
- Where
- France
- Volunteers
- 90 people
- Sponsor
- University Hospital, Brest
Osteoarthritis, Hip, Rheumatoid Arthritis
Exception Cementless Hip Stem
This study is a multicenter, retrospective and prospective, non-controlled, non-randomized post market clinical follow-up study.
- Conditions
- Osteoarthritis, Hip, Rheumatoid Arthritis, Inflammatory Arthritis, Congenital Hip Dysplasia
- Trial name
- Exception (NCT04349046)
- Testing
- Total hip arthoplasty (THA)
- Where
- 6 sites in Belgium, France
- Volunteers
- 332 people
- Sponsor
- Zimmer Biomet
Hip Dislocation, Congenital, Hip Dysplasia, Congenital, Nonsyndromic
Global Hip Dysplasia Registry
Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint.
- Conditions
- Hip Dislocation, Congenital, Hip Dysplasia, Congenital, Nonsyndromic, Congenital Dysplasia of the Hip, Congenital Hip Dislocation
- Trial name
- GHDR (NCT04117685)
- Testing
- Observational
- Where
- Canada
- Volunteers
- 5,000 people
- Sponsor
- University of British Columbia
Hip Dysplasia
Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia
This effectiveness trial will investigate if patients with hip dysplasia randomised to exercise and patient education have a different mean change in self-reported pain measured by the Copenhagen Hip and Groin Outcome Score…
- Trial name
- MovetheHip (NCT04795843)
- Testing
- Exercise and patient education, Usual Care
- Where
- 2 sites in Denmark
- Volunteers
- 200 people
- Sponsor
- University of Aarhus
Osteoarthritis, Avascular Necrosis of Bone of Hip
Vivacit-E Post-market Follow-up Study
The objectives of this study are to obtain clinical performance (outcomes) data and survivorship for commercially available Vivacit-E (HXPE) liners.
- Conditions
- Osteoarthritis, Avascular Necrosis of Bone of Hip, Post-traumatic; Arthrosis, Congenital Hip Dysplasia
- Trial name
- NCT03226808
- Testing
- Vivacit-E Liner
- Where
- 5 sites in United States
- Volunteers
- 245 people
- Sponsor
- Zimmer Biomet
Degenerative Joint Disease of Hip, Osteoarthritis, Hip
Maxera Large Cups - Canada
This study is monocentric, retrospective and prospective, non-controlled, consecutive series Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data of the Largest Zimmer® Maxera™ Cup…
- Conditions
- Degenerative Joint Disease of Hip, Osteoarthritis, Hip, Avascular Necrosis of Hip, Post-Traumatic Osteoarthritis of Hip
- Trial name
- Maxera Canada (NCT04348968)
- Testing
- Total hip arthroplasty
- Where
- Canada
- Volunteers
- 20 people
- Sponsor
- Zimmer Biomet
Rheumatoid Arthritis, Osteoarthritis
A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement
The purpose of this study is to monitor the performance of the Summit™ hip in the treatment of patients with hip joint disease requiring a total hip replacement.
- Conditions
- Rheumatoid Arthritis, Osteoarthritis, Post-traumatic Arthritis, Collagen Disorders
- Trial name
- NCT00208390
- Testing
- Summit Tapered Hip System
- Where
- 5 sites in China, Hong Kong and 3 more
- Volunteers
- 275 people
- Sponsor
- DePuy International
Osteoarthritis, Avascular Necrosis
Trilogy AB Acetabular Hip System Post Approval Study
This is a post-approval study with prospective enrollment in the United States and a retrospective enrollment outside the United States to obtain functional, quality of life and radiographic data, which will facilitate assessment…
- Conditions
- Osteoarthritis, Avascular Necrosis, Congenital Hip Dysplasia, Traumatic Arthritis
- Trial name
- NCT00715026
- Testing
- Trilogy AB Acetabular Hip Implant System
- Where
- 2 sites in United States
- Volunteers
- 31 people
- Sponsor
- Zimmer Biomet